Literature DB >> 8811770

Use of hormone replacement therapy. Hormone replacement therapy may not always be right choice to prevent cardiovascular disease.

S Panico, R Galasso, E Celentano, L Frova, R Capocaccia, F Berrino.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8811770      PMCID： PMC2351996          DOI： 10.1136/bmj.313.7058.687

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Hormone therapy to prevent disease and prolong life in postmenopausal women.

Authors:  D Grady; S M Rubin; D B Petitti; C S Fox; D Black; B Ettinger; V L Ernster; S R Cummings
Journal:  Ann Intern Med       Date:  1992-12-15       Impact factor: 25.391

2.  HRT: an analysis of benefits, risks and costs.

Authors:  E Daly; M Roche; D Barlow; A Gray; K McPherson; M Vessey
Journal:  Br Med Bull       Date:  1992-04       Impact factor: 4.291

3.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

Review 4.  A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.

Authors:  B M Psaty; S R Heckbert; D Atkins; D S Siscovick; T D Koepsell; P W Wahl; W T Longstreth; N S Weiss; E H Wagner; R Prentice
Journal:  Arch Intern Med       Date:  1993-06-28
  4 in total
  1 in total

1.  Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations.

Authors:  S Panico; R Galasso; E Celentano; A V Ciardullo; L Frova; R Capocaccia; M Trevisan; F Berrino
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.